Table I.

Clinical characteristics of patients involved in the present study.

Patient ID	Gender	Age	Site	M/NM
1	Male	11	Tibia	M
2	Male	13	Femur	M
3	Male	9	Femur	M
4	Female	18	Femur	NM
5	Female	25	Tibia	M
6	Female	12	Humerus	M
7	Male	12	Femur	M
8	Female	20	Tibia	NM
9	Male	40	Ulna	M
10	Female	35	Femur	M
11	Male	12	Tibia	M
12	Female	15	Femur	NM
13	Male	17	Tibia	NM
14	Female	15	Humerus	NM
15	Female	16	Tibia	M
16	Male	18	Tibia	M
17	Male	14	Humerus	M
18	Female	34	Tibia	M
19	Male	21	Femur	M
20	Female	20	Tibia	M
21	Female	8	Humerus	NM
22	Female	7	Tibia	M
23	Male	9	Femur	M
24	Male	13	Tibia	M
25	Female	16	Humerus	M
26	Male	18	Tibia	M
27	Male	16	Femur	NM
28	Female	26	Femur	NM
29	Male	55	Tibia	NM
30	Female	50	Femur	NM
31	Male	25	Ulna	M
32	Female	27	Tibia	M
33	Female	14	Tibia	M
34	Male	16	Femur	M
35	Male	12	Tibia	M
36	Female	19	Femur	NM
37	Male	8	Ulna	NM
38	Female	10	Tibia	M
39	Male	12	Femur	NM
40	Male	11	Tibia	M

M, metastasis; NM, no metastasis.